Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methane SCHEMBL2480640 | 0.98 | TSHR (0.34) | TSHRCYP2C19ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL28672980 | 0.97 | TSHR (0.32) | TSHRCYP2C19 | |
| SCHEMBL715609 | 0.82 | TSHR (0.37) | TSHRCYP2C19ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL2831752 | 0.80 | TSHR (0.36) | TSHRCYP2C19ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL2832088 | 0.80 | TSHR (0.36) | TSHRCYP2C19ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL2192555 | 0.80 | TSHR (0.36) | TSHRCYP2C19ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL1840485 | 0.80 | TSHR (0.36) | TSHRCYP2C19ALDH1A1SMN1; SMN2LMNA | |
| Hydrochloric Acid SCHEMBL11579187 | 0.78 | TSHR (0.34) | TSHRCYP2C19ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL1020071 | 0.77 | ALDH1A1 (0.32) | TSHRCYP2C19ALDH1A1SMN1; SMN2 | |
| SCHEMBL3164465 | 0.77 | TSHR (0.37) | TSHRCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11485118-B2 | Resin molded product | AICELLO CORPORATION (JP) | 2022-11-01 | — | — | US | disclosed |
| US-20200283590-A1 | RESIN MOLDED PRODUCT | AICELLO CORPORATION (JP) | 2020-09-10 | — | — | US | disclosed |
| US-20190300665-A1 | RESIN MOLDED PRODUCT | AICELLO CORPORATION (JP) | 2019-10-03 | — | — | US | disclosed |
| CN-104066431-B | Pyrazine kinase inhibitors | 波托拉医药品公司 | 2017-03-08 | — | — | CN | disclosed |
| CN-103282352-B | Benzamides and nicotinamide as SYK regulator | 波托拉医药品公司 | 2016-08-10 | — | — | CN | disclosed |
| CN-101801995-B | Antibacterial peptide | AMP THERAPEUTICS GMBH & CO KG | 2013-10-30 | — | — | CN | disclosed |
| CN-103339111-A | Bicyclic acetyl-CoA carboxylase inhibitors | NOVARTIS AG | 2013-10-02 | — | — | CN | disclosed |
| EP-2331507-A2 | HETEROCYCLIC CARBOXAMIDE COMPOUNDS | Astellas Pharma Inc. (JP) | 2011-06-15 | — | — | EP | disclosed |
| CN-101801995-A | Antibacterial peptide | AMP THERAPEUTICS GMBH & CO KG | 2010-08-11 | — | — | CN | disclosed |
| WO-2010032875-A2 | HETEROCYCLIC CARBOXAMIDE COMPOUNDS | ASTELLAS PHARMA INC. (JP) | 2010-03-25 | — | — | WO | disclosed |
| EP-2106396-A2 | CHEMICAL COMPOUNDS 637: PYRIDOPYRIMIDINEDIONES AS PDE4 INHIBITORS | AstraZeneca AB (SE) | 2009-10-07 | — | — | EP | disclosed |
| WO-2008084223-A2 | CHEMICAL COMPOUNDS 637: PYRIDOPYRIMIDINEDIONES AS PDE4 INHIBITORS | ASTRAZENECA AB (SE) | 2008-07-17 | — | — | WO | disclosed |